Fri, Dec 26, 2014, 7:36 PM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Insmed Incorporated Message Board

  • accugrowth accugrowth Dec 5, 2012 3:17 PM Flag

    PubMed IGFBP-3 for ROP Article - basic research supports Premacure

    The following article supports the work being done by Premacure. Iplex is not an INSM priority for 2013; however, 2014 is not that far away. The new CEO stated in the last CC that he would keep investors updated on Iplex. To be determined in February- Did Ipsen ever get around to signing the release???

    Insulin-like growth factor binding protein-3 in preterm infants with retinopathy of prematurity.
    Gharehbaghi MM, Peirovifar A, Sadeghi K, Mostafidi H.
    Indian J Ophthalmol. 2012 Nov;60(6):527-30.

    Conclusion: Our data demonstrated that the blood levels IGFBP-3 was significantly lower in the patients with ROP and it is suspected that IGFBP-3 deficiency in the premature infants may have a pathogenetic role in proliferative ROP.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
INSM
15.37+0.08(+0.52%)Dec 26 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Virgin America Inc.
NASDAQFri, Dec 26, 2014 4:00 PM EST
Southwestern Energy Co.
NYSEFri, Dec 26, 2014 4:02 PM EST